Plavix may be treatment for dogs at risk of thromboembolic disease

July 14, 2010

Companion animals that have a long-term need for anticoagulant drug therapies may soon find help in a top-selling antiplatelet drug marketed to humans: clopidogrel, commonly known by the trade-name Plavix.

Researchers in the University of Georgia College of Veterinary Medicine have found that clopidogrel may be a safe and effective treatment for dogs that need long-term anticoagulant therapy. In addition, it may offer a safe alternative to NSAIDs for treating dogs at risk of thromboembolism due to concurrent therapeutic use of .

Other than aspirin, there are currently no approved antiplatelet drug therapies available to prophylactically treat companion animals with known or suspected hypercoagulability. Anticoagulants such as heparin, which must be administered by injection, are often used instead, but for patients who need long-term treatment, the researchers on the study said many animal owners are reluctant to administer injectable drugs to their pets.

In addition, critically ill dogs are at risk for thromboembolic disease, including pulmonary and aortic thromboembolism, both of which are associated with severe illness and death. Dogs that develop and are subsequently treated with thrombolytic agents are at a substantial risk of hemorrhage or metabolic instability.

The researchers wanted to evaluate clopidogrel as a potential treatment for dogs with hypercoagulability due to excessive platelet activation. Clopidogrel, which is only available as an oral therapy, has been safely administered to cats, rabbits and calves, but little has been published about its effects in dogs.

In a study of healthy dogs, researchers found that most dogs had a significant inhibition of platelet function within three hours of receiving clopidogrel. All of the dogs in the study tolerated the drug well and showed no evidence of bruising, or other adverse effects. In addition, platelet activity returned to normal levels within approximately seven days after the drug was discontinued, which is similar to the response found in humans.

The researchers caution that their study only provides data on the effectiveness of in healthy dogs, and not on dogs that are critically ill or receiving other drugs. Further pharmacokinetic and pharmacodynamic studies in critically ill canine patients are planned, in addition to studies evaluating this drug in healthy horses.

Explore further: Canine genome is studied in Britain

More information: The study is published in the July 2010 issue of The American Journal of Veterinary Research; it can be found online at

Related Stories

Canine genome is studied in Britain

July 12, 2005

Some dog breeds are more susceptible to particular diseases than others and British scientists want to identify their genetic predisposition.

Dog 'laugh' silences other dogs

December 5, 2005

Washington state researchers report discovering what might be the sound of dog laughter. The scientists say the long, loud pant they recorded has a calming or soothing effect on the behavior of other dogs, ABC News reported.

Recommended for you

New gene map reveals cancer's Achilles heel

November 25, 2015

Scientists have mapped out the genes that keep our cells alive, creating a long-awaited foothold for understanding how our genome works and which genes are crucial in disease like cancer.

Insect DNA extracted, sequenced from black widow spider web

November 25, 2015

Scientists extracted DNA from spider webs to identify the web's spider architect and the prey that crossed it, according to this proof-of-concept study published November 25, 2015 in the open-access journal PLOS ONE by Charles ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.